HATCHLOGO only med rez.JPG
Hatch Medical and VascuTech Medical Partner to Commercialize Advanced Radial Sheath and Micro-Introducer Lines
October 20, 2020 15:01 ET | Hatch Medical, L.L.C.
SANTA ROSA BEACH, Fla., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C. (www.hatchmedical.com) announced recently that it has entered...
Reports and Data.jpeg-01
Contrast Media Injectors Market To Reach USD 2.86 Billion By 2027 | Reports And Data
February 20, 2020 11:00 ET | Reports and Data
NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- The Global Contrast Media Injectors Market is forecast to reach USD 2.86 Billion by 2027, according to a new report by Reports and Data. A contrast agent...
InnovaHealth-Radiaction.jpg
InnovaHealth Partners Invests in Radiaction, the Technology Leader in Robotic Radiation Protection
January 09, 2020 20:11 ET | InnovaHealth Partners; Radiaction
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Radiaction (“Radiaction” or the “Company”) and InnovaHealth Partners, LP (“InnovaHealth”) jointly announce today that InnovaHealth has made a growth...
Colibri HV Logo
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
September 24, 2019 16:01 ET | Colibri Heart Valve, LLC
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was...
BBRAUN SE_GREEN (1).jpg
B. Braun Interventional Systems Expands its Congenital and Structural Heart Portfolio With the EmeryGlide™ MR Conditional Guidewire From Nano4Imaging
August 29, 2019 15:09 ET | B. Braun Medical Inc.--US
BETHLEHEM, Pa., Aug. 29, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS), a company dedicated to providing innovative solutions in the field of congenital and structural...
Colibri HV Logo
Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
May 14, 2019 10:00 ET | Colibri Heart Valve, LLC
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Transparency Market Research.jpg
Interventional Cardiology Devices Market to be worth US$11.16 bn by 2022, Says TMR
May 23, 2018 09:38 ET | Transparency Market Research
Albany, NY, May 23, 2018 (GLOBE NEWSWIRE) -- The prevailing competitive landscape in the global interventional cardiology devices market is characterized by emerging forces of consolidation,...
Colibri HV Logo
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
May 04, 2018 11:09 ET | Colibri Heart Valve, LLC
Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the Colibri transcatheter aortic valve implantation...
Transparency Market Research.jpg
Interventional Cardiology Devices Market is projected at a CAGR of 2.9% by 2022, globally: Transparency Market Research
February 06, 2018 07:47 ET | Transparency Market Research
Albany, NY, Feb. 06, 2018 (GLOBE NEWSWIRE) -- As per a market research report by Transparency Market Research, the world Interventional Cardiology Devices Market is considered to be extremely...
Colibri HV Logo
Colibri Heart Valve Receives European Patent for a Method of Making a Pre-packaged, Sterilized Dry Heart Valve, Pre-mounted on a Delivery Catheter
April 27, 2016 08:00 ET | Colibri Heart Valve LLC
BROOMFIELD, CO , April 27, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, has received notification from the European Patent Office that patent...